Fax: (713) 794 4385
Male breast cancer according to tumor subtype and race †
A population-based study
Article first published online: 22 JAN 2013
Copyright © 2013 American Cancer Society
Volume 119, Issue 9, pages 1611–1617, 1 May 2013
How to Cite
Chavez-MacGregor, M., Clarke, C. A., Lichtensztajn, D., Hortobagyi, G. N. and Giordano, S. H. (2013), Male breast cancer according to tumor subtype and race . Cancer, 119: 1611–1617. doi: 10.1002/cncr.27905
The ideas and opinions expressed herein are those of the authors, and endorsement by the State of California Department of Public Health, the National Cancer Institute, and the Centers for Disease Control and Prevention or their contractors and subcontractors is not intended nor should be concluded.
- Issue published online: 22 APR 2013
- Article first published online: 22 JAN 2013
- Manuscript Accepted: 12 OCT 2012
- Manuscript Revised: 13 SEP 2012
- Manuscript Received: 3 JUL 2012
- breast cancer;
- population-based study;
- breast cancer subtypes
Breast cancer occurs rarely in men. To the authors' knowledge, no population-based estimates of the incidence of human epidermal growth factor receptor 2 (HER2)-positive breast cancer or of the distribution of breast cancer subtypes among male breast cancer patients have been published to date. Therefore, the objective of the current study was to explore breast tumor subtype distribution by race/ethnicity among men in the large, ethnically diverse population of California.
This study included men who were diagnosed with invasive breast cancer between 2005 and 2009 with known estrogen receptor (ER) and progesterone receptor (PR) (together, hormone receptor [HR]) status and HER2 status reported to the California Cancer Registry. Among the men with HR-positive tumors, survival probabilities between groups were compared using log-rank tests.
Six hundred six patients were included. The median age at diagnosis was 68 years. Four hundred ninety-four men (81.5%) had HR-positive tumors (defined as ER-positive and/or PR-positive and HER2-negative). Ninety men (14.9%) had HER2-positive tumors, and 22 (3.6%) had triple receptor-negative (TN) tumors. Among the patients with HR-positive tumors, non-Hispanic black men and Hispanic men were more likely to have PR-negative tumors than non-Hispanic white men. No statistically significant differences in survival were observed according to tumor subtype (P = .08). Differences in survival according to race/ethnicity were observed among all patients (P = .087) and among those with HR-positive tumors (P = .0170), and non-Hispanic black men had poorer outcomes.
In this large, representative cohort of men with breast cancer, the distribution of tumor subtypes was different from that reported for women and varied by patient race/ethnicity. Non-Hispanic black men were more likely to have TN tumors and ER-positive/PR-negative tumors than white men. Cancer 2013. © 2013 American Cancer Society.